Alzil

Quick links to important sections

Alzil

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Alzil

Quick Facts About Alzil (Donepezil)

Property Description
Active Ingredient Donepezil hydrochloride
Form Differentiation Standard oral tablets and Orally Disintegrating Tablets (ODT)
Pharmacological Class Selective Acetylcholinesterase Inhibitor
Common Use Symptomatic treatment of Alzheimer's dementia
Origin Fully synthetic compound

What Type of Medicine is Alzil and What Does it Contain?

Alzil is a prescription drug containing the active ingredient donepezil, a synthetic compound provided in an oral tablet form. This medication belongs to a group of medicines known as cholinesterase inhibitors. Donepezil itself is a piperidine derivative. The drug acts within the central nervous system, and its chemical structure allows for a prolonged effect and once-daily use.

What is Alzil's Therapeutic Purpose?

The primary therapeutic use of Alzil is the symptomatic management of mild, moderate, and severe Alzheimer’s dementia. Donepezil is used across the spectrum of Alzheimer's disease severity. The medicine is intended to help stabilize or improve cognitive symptoms, such as difficulties with memory and thinking. While it does not cure the underlying disease, its role is to support functional independence and help patients maintain their ability to engage in daily activities.

How is Alzil Positioned in Treatment?

Alzil is an Alzheimer's treatment that is often available in specialized forms, such as the Orally Disintegrating Tablet (ODT). The availability of the ODT formulation offers an alternative for patients who may have difficulty swallowing standard tablets, which can be a challenge in dementia care. This drug is utilized to address cognitive function and activities of daily living for individuals with dementia.

What side effects are possible with Alzil?

Possible Side Effects and Safety Information

The safety profile of Alzil (donepezil) is officially classified according to frequency and body system, with reported adverse events reflecting the expected effects of a cholinesterase inhibitor.


Frequency Classification of Adverse Reactions

The most commonly reported side effects across regulatory clinical trials involve the Gastrointestinal and Nervous Systems.

Classification Examples of Officially Listed Adverse Reactions
Very Common Headache, Diarrhea, Nausea.
Common Insomnia, Vomiting, Dizziness, Muscle cramps, Fatigue, Anorexia, Abnormal dreams, Accidents (including falls).
Uncommon Bradycardia (slow heartbeat), Seizures (Convulsions), Gastrointestinal bleeding, Peptic Ulcer Disease.
Rare Neuroleptic Malignant Syndrome (NMS), Hepatitis, Bladder outflow obstruction.

Serious Safety Constraints and Warnings

Official regulatory documents note specific serious adverse reactions and high-level safety constraints:

  • Serious Adverse Reactions: Documented risks include Bradycardia and Heart Block, Syncope (fainting), Gastrointestinal Bleeding, Peptic Ulcer Disease, and Seizures. Post-marketing reports also cite QTc interval prolongation and Torsade de Pointes.
  • Population-Specific Cautions: Caution is necessary for patients with a history of Ulcer Disease or pre-existing Cardiac Conduction abnormalities (e.g., "sick sinus syndrome"). The drug class may also worsen symptoms in individuals with a history of Asthma or Obstructive Pulmonary Disease.
  • Time-Related Pattern: Common gastrointestinal effects like Nausea and Vomiting are officially documented as appearing more frequently at the initiation of treatment and following increases in dosage, but are often transient.

This regulatory structure defines the drug's risk characteristics, distinguishing between highly common, generally manageable effects and rare, clinically significant systemic risks documented across official labeling.

Overdose and Emergency Response

Alzil (donepezil) is a cholinesterase inhibitor, and taking more than the prescribed amount can lead to an exaggerated cholinergic effect, a condition known as a cholinergic crisis. This is a serious medical emergency that requires immediate professional attention.

Symptoms of Overdose

The signs and symptoms of an Alzil overdose are related to increased acetylcholine levels and may include:

  • Severe and persistent nausea and vomiting
  • Excessive sweating, salivation, or drooling
  • Slowed heart rate (bradycardia) and low blood pressure (hypotension)
  • Muscle weakness, which can progress to involving the respiratory muscles, leading to troubled or depressed breathing
  • Collapse, generalized weakness, or seizures

When to Seek Immediate Help

If you or someone you are caring for has taken more than the prescribed dose of Alzil, or if any of the above severe symptoms are observed, seek emergency medical attention immediately.

  • Call your local emergency services or the Poison Control Center right away.
  • Do not wait for symptoms to worsen. Early intervention is critical to manage the potentially life-threatening effects of an overdose, such as severe respiratory or cardiovascular complications. The management of an overdose often involves general supportive care and the use of an antidote, such as atropine, administered by healthcare professionals.

Therapeutic Uses of Alzil

What Alzil Treats: Main Uses and Benefits

Alzil is commonly used in conditions that involve the progressive decline of cognitive function, supporting the patient during difficult episodes by easing distress in these core mental processes. The medication is relevant for easing symptoms that interfere with daily functioning, such as difficulties with memory, attention, and general mental confusion associated with Alzheimer's dementia. The medication may be part of symptomatic management across conditions characterized by periods of heightened symptoms, including mild, moderate, and severe forms.


Maintaining Day-to-Day Functional Independence

The medication is relevant in clinical settings marked by interference with the patient's functional capacity and Activities of Daily Living (ADLs). It is applied in scenarios where additional management of discomfort is required, supporting the patient during difficult episodes by easing distress and may assist with maintaining functional stability.

Symptomatic Support Across All Severity Levels

This use may assist with easing the overall symptom load and is relevant for managing symptoms that interfere with daily comfort, supporting general well-being during symptomatic phases as the condition progresses. The medication assists in the management of behavioral and psychosocial manifestations and contributes to easing the overall symptom load.


Quick Fact: Symptomatic Support for Cognitive Decline
Alzil is relevant for easing symptoms that cluster into patterns requiring supportive management and is commonly used to help with symptoms that interfere with daily functioning, including cognitive impairment and loss of functional independence in Alzheimer's disease.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Eligibility Scope

Populations for Whom Use is Allowed Populations for Whom Use is Contraindicated
Adults (18 years and older) for the approved indication. Known hypersensitivity to donepezil hydrochloride.
Older Adults; use is permitted without specific geriatric-related limitations. Known hypersensitivity to piperidine derivatives (a related compound class).

Condition-Based and Physiological Restrictions

Not Recommended (Safety/Efficacy Not Established) Use with Caution/Restricted (Conditional Eligibility)
Pediatric patients (under 18 years). Patients with specific cardiac conduction abnormalities, such as heart block.
Severe hepatic impairment (due to lack of established data). History of peptic ulcer disease or concurrent use of NSAIDs.
Pregnancy (unless clearly necessary). History of asthma or obstructive pulmonary disease.
Lactation/Breastfeeding (status is not recommended). History of seizure disorder or bladder outflow obstruction.
Renal Impairment is generally permitted without dosage adjustment.

Official Eligibility Summary

Official regulatory documents define Alzil's eligibility by establishing absolute contraindications limited solely to hypersensitivity to the drug or related compounds. Use is not recommended for pediatric, pregnant, or severely hepatic impaired populations because safety and efficacy have not been formally established. For all other eligible adults, use is conditional, requiring close monitoring if the patient has a history of specific cardiac, pulmonary, or gastrointestinal disorders.

What should I know about interactions with other medicines?

Alzil's drug interaction profile is defined by its two primary mechanisms: its pharmacologic action as an acetylcholinesterase inhibitor and its metabolism by liver enzymes.

Due to its mechanism, Alzil is expected to have a synergistic effect with other cholinomimetics and a potential antagonistic effect with anticholinergic agents. Coadministration with other cholinesterase inhibitors is generally not recommended due to the increased risk of pronounced cholinergic side effects. Caution is also advised when combining it with drugs that slow the heart rate (e.g., certain beta-blockers or antiarrhythmics), as this may increase the risk of bradycardia or syncope.

Alzil is primarily metabolized by the cytochrome P450 isoenzymes CYP3A4 and CYP2D6. Therefore, medicines that inhibit these enzymes (e.g., ketoconazole, quinidine, fluoxetine, erythromycin) may increase Alzil levels, potentially leading to increased side effects. Conversely, enzyme inducers (e.g., rifampicin, phenytoin, carbamazepine) may decrease Alzil plasma concentrations, which could reduce its effectiveness. Dose adjustment of Alzil may be necessary when starting or stopping these interacting medications. Lastly, the coadministration of Alzil with Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) requires close monitoring due to an increased risk of gastrointestinal bleeding or peptic ulcers.

Mechanism of Action

How Alzil Works

Alzil's mechanism operates through two distinct primary pathways that influence nerve cell communication and cellular integrity. Its action involves the modulation of central signaling pathways by targeted intervention at specific biological systems.

1. Modulating Synaptic Chemical Messengers

This domain covers the drug's primary action: reversible inhibition of the enzyme acetylcholinesterase (AChE). This inhibition reduces the natural breakdown of the key chemical messenger acetylcholine ( ACh), increasing its concentration and duration in the synaptic space. This modification of the early molecular steps results in more effective ACh-mediated communication, which is relevant for physiological processes within central neural networks.

2. Influencing Neuronal Stability and Cellular Integrity

This separate domain involves the drug's interaction with the Sigma-1 receptor (sigma1R), a protein chaperone. Activation of the sigma1 R engages mechanisms that regulate overactive cellular processes and influence neuronal stability by modulating cellular responses to conditions such as inflammation and excitotoxicity. This mechanism influences feedback regulation within pathways, which results in the modulation of the extracellular milieu and downstream cellular cascades.

Dosage and Administration Information

How to Use Alzil: Administration Guidelines

Alzil (donepezil) is intended for long-term continuous use and is administered via the oral route as either a standard film-coated tablet or an Orally Disintegrating Tablet (ODT). The primary schedule involves a once-daily dose taken in the evening, just prior to retiring. This timing helps establish a consistent administration routine.

Standard Dosage and Titration Protocol

Treatment begins with a 5 mg strength dose, which is maintained once daily for a period of four to six weeks. This initial phase precedes any dose increase to the 10 mg maintenance strength. In some regions, a higher maximum dose of 23 mg once daily is available, which is only initiated after a minimum of three months on the 10 mg regimen.

Administration Details and Special Conditions

Alzil can be taken with or without food. For the ODT formulation, the tablet should be allowed to dissolve directly on the tongue before being swallowed, potentially with water. Crucially, the 23 mg tablet must be swallowed whole and should not be split, crushed, or chewed, a restriction tied to proper drug absorption.

In the event a dose is missed, the schedule should be resumed by taking the next dose at the usual time; it is recommended not to take two doses to compensate for a missed one. For patients with renal impairment, dose adjustments are generally not required, while those with mild to moderate hepatic impairment may require dose escalation based on individual tolerability. The medicine is not recommended for use in individuals under the age of 18.

Recent Clinical Evidence

Alzil: Recent Clinical Evidence

Evidence for Mild to Moderate Alzheimer's Dementia

The initial and core research exploring Alzil was studied in clinical trials for its application in mild to moderate Alzheimer's dementia. The scientific foundation relies mainly on short-term (typically 12 to 24-week) controlled trials that evaluated outcomes between individuals taking the medicine and those receiving an inactive placebo. These trials included older adults who had received a clinical diagnosis of the condition.

Researchers monitored key outcomes, which included scores on scales reflecting daily functioning or activity level, along with standardized measures of thinking and memory. Data show patterns related to measurements on standardized scales for cognitive function and global clinical state where scores were recorded between the treated group and the placebo group at the short-term primary endpoints. This research contributes to the available evidence base.


Evidence for Moderate to Severe Alzheimer's Dementia

Alzil was evaluated in controlled research exploring its application for individuals with moderate to severe stages of Alzheimer's dementia. These studies included populations with more advanced functional limitations and employed specialized scales to monitor scores on cognitive function. Research also explored whether outcomes varied when comparing various dose levels of the medicine in these later stages.

The data show patterns related to recorded scores on severe cognitive scales and functional capacity when treated groups was observed in comparison to placebo over the defined study intervals. However, when comparing the measurements between different doses in this more severe population, findings were mixed regarding the registered scores on functional outcomes at the highest studied dose. This is an example of where evidence quality varies across studies.


Research Gaps and Uncertainty

The available evidence base, while extensive in the short-term, presents several areas of uncertainty recognized in scientific reviews. Follow-up durations were limited in the most rigorous placebo-controlled trials, meaning the long-term impact on functional capacity is not fully established. Evidence quality varies across studies concerning measurements of behavioral and psychosocial symptoms, where findings were mixed. The research highlights what is known — and what is still uncertain — in the evidence landscape.

Key Studies & References Donepezil (Oral Route): NIH MedlinePlus Drug Information

Frequently Asked Questions (FAQ)

Common questions about Alzil (FAQ)


Q: Is Alzil used to treat all types of memory problems?

Official documents state that Alzil is for the symptomatic management of Alzheimer's dementia only. Its effectiveness for treating other types of memory problems, such as age-related cognitive decline, has not been formally established in regulatory studies.


Q: How is Alzil different from other drugs used for similar conditions?

According to official product information, Alzil is a selective inhibitor of the enzyme acetylcholinesterase, which is the predominant form in the brain. This selectivity is highlighted in regulatory descriptions and is what distinguishes it from some other treatments in the same general class.


Q: How quickly can someone expect to see any effects from Alzil?

Studies and clinical information indicate that the concentration of the medication reaches a stable level, or steady-state, within about three weeks after beginning treatment. Observable benefits in cognitive or functional symptoms may be observed after a month or more.


Q: Does Alzil stop the progression of the condition it treats?

Official regulatory information describes Alzil as a symptomatic treatment. It is stated that there is no evidence that the medication alters or stops the course of the underlying disease process.


Q: Are there any long-term side effects associated with taking Alzil?

While all reported side effects are categorized by frequency in official labeling (e.g., Rare, Uncommon), the full scope of the long-term impact on functional ability is not fully established. This is because the most rigorous clinical trials had limited follow-up durations. Serious reactions documented in official sources include Bradycardia (slow heart rate) and Seizures.


Q: Can Alzil be taken at the same time as cold or allergy medicine?

Some common cold and allergy medications contain substances known as anticholinergic agents. Official warnings state that when Alzil is taken with anticholinergic agents, it may have an antagonistic effect. This interaction could potentially reduce the effectiveness of Alzil.


Q: Is it safe to take supplements, like vitamins or herbs, while on Alzil?

Regulatory patient guidance indicates that individuals should share information about all other products they take with their healthcare providers. This includes prescription and over-the-counter medicines, as well as any supplements, herbs, or vitamins, due to the potential for interactions.


Q: Are there foods or drinks that should be avoided while taking Alzil?

Official information states that Alzil can be taken with or without food. While the medication is not known to interact directly with alcohol, consuming alcohol may worsen some of the common side effects that are possible with the drug, such as nausea or vomiting.


Q: Does Alzil require any special monitoring or regular blood tests?

Official guidance confirms that, unlike some other medications in this class, Alzil does not typically require routine laboratory monitoring or baseline blood tests before treatment is started.


Q: Can Alzil affect driving or operating machinery?

Regulatory documents include a warning about driving or operating machinery. This is because common side effects such as fatigue, dizziness, and muscle cramps are noted as possible, particularly when treatment begins or the dose is increased.


Q: Does taking Alzil affect a person's mood or behavior?

Official product labeling confirms that changes in mood and behavior are listed as potential adverse reactions. For instance, both agitation and aggressive behavior are documented as common side effects.


Q: What happens if a person suddenly stops taking Alzil?

Studies show that discontinuing Alzil leads to a loss of the medication's therapeutic benefits. It is noted that the symptoms of the condition may be expected to worsen after stopping the medicine.


Q: Is there any difference between the brand name and the generic version of Alzil?

According to the US Food and Drug Administration (FDA), an approved generic version meets the same rigorous standards as the brand-name version. This includes being identical in dosage, safety, strength, quality, performance characteristics, and intended use.


Q: Does Alzil cause weight changes?

Official product labeling indicates that loss of appetite (anorexia) and weight loss are listed as common side effects.


Q: Why is Alzil taken only once a day?

The reason for the once-daily schedule is due to the chemical properties of the active ingredient. Its long half-life, which is approximately 70 hours, supports the administration of a single dose per day to maintain a steady concentration in the body.


Q: What should a patient tell their doctor before starting Alzil?

Patient guidance indicates that individuals should share a complete history with their doctor before starting treatment. This includes all current medications and supplements, as well as a history of health problems like heart issues, lung disease, seizures, or stomach ulcers.


Q: Are there any specific patient groups where Alzil has been less effective in studies?

Research exploring the use of Alzil in individuals with more severe stages of the condition showed mixed findings concerning functional outcomes when comparing different dose levels. This is noted in scientific reviews as a point where evidence quality varied.


Q: Does alcohol consumption affect how Alzil works?

Official product information states the medication is not known to interact directly with alcohol. However, consuming alcohol may worsen some of the common side effects that are possible with the drug.


Q: What are the signs of a serious allergic reaction to Alzil?

Official warnings describe signs of a serious allergic reaction as sudden rash, itching, or swelling of the face, lips, tongue, or other parts of the body. Other signs include difficulty breathing or wheezing.


Q: What is the role of Alzil compared to non-drug treatments?

Alzil is described in official documents as a symptomatic treatment. Its role is to support the patient's functional independence and help maintain their ability to engage in daily activities, rather than providing a cure.


Q: Does Alzil make a person feel sleepy?

Official labeling lists fatigue and dizziness as common side effects. The product information describes the standard timing for administration as the evening prior to retiring, possibly to accommodate the potential for these effects.


Q: What are the common misunderstandings about what Alzil can achieve?

Official information emphasizes that Alzil provides symptomatic management and is not a cure for the condition. The evidence base is primarily built on short-term studies, and reviews note that the long-term impact on functional capacity is not fully established.


Q: How long does the effect of one dose of Alzil last?

The long half-life of the active ingredient, which is approximately 70 hours, supports the once-daily administration schedule. This chemical property means the effect of a single dose is sustained throughout a full 24-hour period.


Q: How reliable is the evidence base for Alzil?

The evidence base is largely built on short-term controlled trials. Scientific reviews note that follow-up durations were limited and that the quality of evidence varies concerning the long-term impact on functional capacity.


Q: What is the general safety classification of Alzil?

The safety profile is defined by officially documented side effects, which are categorized by frequency (e.g., Very Common, Common). Serious risks documented in official sources include potential gastrointestinal bleeding, slow heart rate (bradycardia), and seizures.

How should Alzil be stored and disposed of?

How to Store and Dispose of Alzil?

The storage and disposal of Alzil (donepezil) must adhere strictly to official regulatory guidelines to maintain its stability and ensure safety.

Storage Requirements

Alzil tablets must be kept at Controlled Room Temperature, which generally ranges from 20 C to 25 C. The medicine must be stored in its original, closed container and protected from moisture, excessive heat, and freezing. For the safety of the household, Alzil must be kept out of the sight and reach of children at all times.

Disposal Instructions

Unused or expired Alzil must not be disposed of via wastewater (e.g., flushing) or in the regular household trash. The official method for discarding the medication is by utilizing a community drug take-back program or by consulting a pharmacist for disposal guidance according to local environmental regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Alzil found in:

A-Z Index: